Sponsor

Ciusss de L'Est de l'Île de Montréal

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Ciusss de L'Est de l'Île de Montréal appears in 14 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials14
Recruiting shown2
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

14 shown
Home-Based tDCS for Depression in BPDNCT06972368 · lead sponsor · 2026-01-01
RECRUITING
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic DisordersNCT05704582 · lead sponsor · 2023-02-01
RECRUITING
Combining Virtual Reality and Hypnosis to Alleviate Chronic Pain in Elderly Patients with Hand ArthritisNCT06833905 · lead sponsor · 2025-04-01
NOT_YET_RECRUITING
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective SurgeryNCT06500143 · lead sponsor · 2024-10-09
COMPLETED
Avatar Therapy in Virtual Reality for Treatment-Resistant Major Depressive Disorder: A Pilot StudyNCT07112261 · lead sponsor · 2024-08-01
ACTIVE_NOT_RECRUITING
Thoracic Paravertebral Block Anesthesia for Breast Cancer SurgeryNCT05711030 · lead sponsor · 2022-11-04
UNKNOWN
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 DiabetesNCT05385211 · lead sponsor · 2022-04-30
COMPLETED
ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology TreatmentNCT05787145 · lead sponsor · 2021-03-10
UNKNOWN
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to PaclitaxelNCT04237090 · lead sponsor · 2020-02-14
COMPLETED
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health DisordersNCT05726617 · lead sponsor · 2019-09-24
UNKNOWN
Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory HallucinationsNCT04054778 · lead sponsor · 2019-04-01
UNKNOWN
Citalopram Titration in Early Non-responder Patients With Major Depressive DisordersNCT03899285 · lead sponsor · 2018-01-08
COMPLETED
Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant SchizophreniaNCT03585127 · lead sponsor · 2017-03-01
COMPLETED
Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in SchizophreniaNCT03148639 · lead sponsor · 2015-09-01
COMPLETED

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Ciusss de L'Est de l'Île de Montréal as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
cetirizine1
diphenhydramine1

Sponsor roles

lead sponsor14
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.